Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc. (LXRX)

FDA Applications

Note: This list only includes applications that have been responded to by the FDA.

ApplicationProduct NameActive IngredientFormStrengthStatus
NDA216203 - LEXICON PHARMS INC
INPEFASOTAGLIFLOZINTABLET;ORAL200MGPrescription
INPEFASOTAGLIFLOZINTABLET;ORAL400MGPrescription